Hotlinenewswire

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Roche Launches 2 Media Reviews

LOS ANGELES—Roche Laboratories has launched two reviews for its Xenical fat-fighting drug and its influenza pill, Tamiflu: one for the two drugs’ general-market media buying account and another for direct response buying. The combined budget for the assignments is estimated at $50 million. Participating in the dual searches will be New York-based incumbents Impiric, a Young & Rubicam shop that handles Tamiflu direct response buying; Media Marketing Solutions, another Y&R entity that handles general market buying for Xenical and Tamiflu; and Initiative Media’s Media Direct Partners, which handles Xenical’s direct response buying account.

Publicis Exits SBC’s $185-250 Mil.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in